XML 42 R27.htm IDEA: XBRL DOCUMENT v3.25.1
FAIR VALUE MEASUREMENTS (Tables)
3 Months Ended
Mar. 31, 2025
Fair Value Disclosures [Abstract]  
Summary of Assets and Liabilities Measured at Fair Value on a Recurring Basis
The following table summarizes the types of assets and liabilities measured at fair value on a recurring basis by level within the fair value hierarchy:
March 31, 2025December 31, 2024
(in millions)Level 1Level 2Level 3TotalLevel 1Level 2Level 3Total
Assets:
Equity securities:
Money market funds$6,255 $— $— $6,255 $8,502 $— $— $8,502 
Publicly traded equity securities(1)
1,189 — — 1,189 1,561 — — 1,561 
Deferred compensation plan340 — — 340 343 — — 343 
Foreign currency derivative contracts— 44 — 44 — 128 — 128 
Total$7,784 $44 $— $7,828 $10,405 $128 $— $10,533 
Liabilities:
Contingent consideration liability$— $— $216 $216 $— $— $206 $206 
Deferred compensation plan340 — — 340 343 — — 343 
Foreign currency derivative contracts— 28 — 28 — — 
Total$340 $28 $216 $584 $343 $$206 $552 
_______________________________
(1)    Publicly traded equity securities include our investments in Arcellx, Inc. (“Arcellx”) of $441 million and Galapagos NV (“Galapagos”) of $419 million as of March 31, 2025, which are subject to contractual sale restrictions. Our investment in Arcellx is restricted until June 2025, and our investment in Galapagos is currently restricted as described further in Note 6. Acquisitions, Collaborations and Other Arrangements.
Summary of Change in Fair Value of Contingent Consideration Liability
The following table summarizes the change in fair value of our contingent consideration liability:
Three Months Ended
March 31,
(in millions)20252024
Beginning balance$206 $228 
Changes in valuation assumptions(1)
— 
Effect of foreign exchange remeasurement(2)
(6)
Ending balance(3)
$216 $222 
________________________________
(1)    Included in Research and development expenses on our Condensed Consolidated Statements of Operations.
(2)    Included in Other (income) expense, net on our Condensed Consolidated Statements of Operations.
(3)    Included in Other long-term liabilities on our Condensed Consolidated Balance Sheets.
Summary of Total Estimated Fair Value and Carrying Value of Senior Unsecured Notes
The following table summarizes the total estimated fair value and carrying value of our senior unsecured notes, determined using Level 2 inputs based on their quoted market values:
(in millions)March 31, 2025December 31, 2024
Fair value$21,886 $23,335 
Carrying value$23,816 $25,562